Abstract
Due to technological advancements and the widespread use of diagnostic imaging modalities in current clinical practice focal liver lesions are increasingly being discovered. Differentiation of these lesions is considered to be critical for determining treatment options. In this regard, histological assessment of the liver, liver biopsy remains a cornerstone in the evaluation and management of patients with liver disease. Despite that sensitive and relatively accurate blood tests used to detect and diagnose liver disease have now become widely available, liver biopsy will remain a valuable diagnostic tool. It has currently three major roles: (1) diagnosis, (2) assessment of prognosis (disease staging), and/or (3) to assist in making therapeutic management decisions.
Several techniques may be used to obtain liver tissue. These include a percutaneous method, a transvenous (transjugular or transfemoral), an endoscopic (transgastric) approach as well as intra-abdominal biopsy (laparoscopic or laparotomic). While in case of percutaneous approach ultrasound guidance is the favored modality, computed tomography (CT), magnetic resonance (MR) and fusion imaging techniques have all been used.
In the present chapter we summarize the current practice of liver biopsy with an emphasis on the indications, contraindications, technique and risk of complications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Taltavull TC. Rethinking the role of liver biopsy in the era of personalized medicine. In: Tagaya N, editor. Liver biopsy. Rijeka: IntechOpen; 2012. https://doi.org/10.5772/53120. Available from: https://www.intechopen.com/books/liver-biopsy-indications-procedures-results/rethinking-the-role-of-liver-biopsy-in-the-era-of-personalized-medicine.
Dahiya N, Middleton WD, Menias CO. Ultrasound-guided visceral biopsies: renal and hepatic. Ultrasound Clin. 2012;7:363–75.
Schüpfer F. De la possibilite de faire “intra vitam” un diagnostic histo-pathologique precis des maladies due foie et de la rate. Sem Med. 1907;27:229.
Randazzo C, Licata A, Almasio PL. Liver biopsy - indications, procedures, results. In: Tagaya N, editor. Liver biopsy. Rijeka: IntechOpen; 2012. https://doi.org/10.5772/52616. Available from: https://www.intechopen.com/books/liver-biopsy-indications-procedures-results/liver-biopsy-indications-procedures-results.
Cadranel J-F, Nousbaum J-B. Current trends in liver biopsy indications for chronic liver diseases. In: Tagaya N, editor. Liver biopsy. Rijeka: IntechOpen; 2012. https://doi.org/10.5772/52618. Available from: https://www.intechopen.com/books/liver-biopsy-indications-procedures-results/current-trends-in-liver-biopsy-indications-for-chronic-liver-diseases.
Strobel D, et al. Contrast-enhanced ultrasound fort the characterisation of focal liver lesions – diagnostic accuracy in clinical practice (DEGUM multicenter trial). Eur J Ultrasound. 2008;59:499–505.
Nufer M, Stuckmann G, Decurtins M. Benigne Tumoren der Leber: Diagnostik und Therapie – eine Übersicht. Schweiz Med Wochenschr. 1999;129:1257–64.
Schirmacher P, Longerich T. Hochdifferenzierte Lebertumore Neue Entwicklungen und ihre diagnostische Relevanz. Pathologe. 2009;30(Suppl 2):200–6.
Khan SA, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(Suppl VI):vi1–9.
Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43–57.
Caselmann WH, et al. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zur Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol. 1999;37:353–65.
Bruix J, Sherman M. AASLD practice guideline: management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. AASLD position paper: Liver biopsy. Hepatology. 2009;49:1017–44.
Huang JY. Role of EUS-guided liver biopsy in benign parenchymal disease (with video). Endosc Ultrasound. 2018;7(4):236–9.
Vijayaraghavan GR, David S, Bermudez-Allende M, Sarwat H. Imaging-guided parenchymal liver biopsy: how we do it. J Clin Imaging Sci. 2011;1(2):30.
Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239–44.
Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology. 1998;28:323–31.
Park HJ, et al. Fusion imaging-guided percutaneous biopsy of focal hepatic lesions with poor conspicuity on conventional sonography. J Ultrasound Med. 2013;32:1557–64.
Ewersten C, et al. Real-time image fusion involving diagnostic ultrasound. AJR. 2013;200:249–55.
Lee MW. Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention. Ultrasonography. 2014;33(4):227–39.
Tagaya N, Makino N, Saito K, Okuyama T, Sugamata Y, Oya M. Types of liver biopsy. In: Tagaya N, editor. Liver biopsy. Rijeka: IntechOpen; 2012. https://doi.org/10.5772/52914. Available from: https://www.intechopen.com/books/liver-biopsy-indications-procedures-results/types-of-liver-biopsy.
Meng HC, et al. Transjugular liver biopsy: comparison with percutaneous liver biopsy. J Gastroenterol Hepatol. 1994;9(5):457–61.
Keshava SN, et al. Transjugular liver biopsy: what to do and what not to do. Indian J Radiol Imaging. 2008;18:245–8.
Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495–500.
Zaman A, Ingram K, Flora KD. Diagnostic liver biopsy. Available from: http://emedicine.medscape.com. Last updated on 18 Nov 2009.
Alswat KA, Mumtaz K, Jafri W. Liver biopsy for histological assessment: the case in favor. Saudi J Gastroenterol. 2010;16(2):133–9.
Strobel D, et al. Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions - results of the prospective multicenter DEGUM interventional ultrasound study (PIUS Study). Ultraschall Med. 2015;36:122–31.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Self Study
Self Study
1.1 Questions
-
1.
When is there an indication for liver puncture?
-
(a)
Liver biopsy should be performed to exclude parenchymal damage in every case of elevated liver function tests
-
(b)
Biopsy is useful only for chronic liver disease
-
(c)
The method of choice is CT-guided hepatic puncture
-
(d)
Hepatic puncture is associated with a relatively high risk and should therefore be limited.
-
(e)
If hepatic metastases are suspected by an unknown primary tumor, a liver biopsy should be carried out early.
-
(a)
-
2.
Which statement is wrong?
-
(a)
Written patient consent should be obtained prior to liver biopsy.
-
(b)
The diagnosis of Budd-Chiari syndrome requires a liver biopsy.
-
(c)
A liver biopsy can be performed while taking ASA.
-
(d)
The most common complication of liver biopsy is pain.
-
(e)
In the hands of an experienced examiner, sonographic liver biopsy is a low complication method.
-
(a)
1.2 Answers
-
1.
When is there an indication for liver puncture?
e. By histological confirmation and, in particular, immunohistochemical support, the pathological finding can in the majority of cases either delimit or definitively differentiate the primary tumor.
-
2.
Which statement is wrong?
b. Atresia of the large liver veins can be clearly diagnosed by sonography or CT imaging. Liver biopsy is not required.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kinkel, H., Călinescu, F.B. (2020). Liver Biopsy for Histopathology. In: Radu-Ionita, F., Pyrsopoulos, N., Jinga, M., Tintoiu, I., Sun, Z., Bontas, E. (eds) Liver Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-24432-3_39
Download citation
DOI: https://doi.org/10.1007/978-3-030-24432-3_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24431-6
Online ISBN: 978-3-030-24432-3
eBook Packages: MedicineMedicine (R0)